
Polpharma: New Hybrid CDMO Offers European Standards on a Lower Cost-Base
David Gonzalez, Head of API Commercial, explains Polpharma’s new ‘hybrid’ business model

David Gonzalez, Head of API Commercial, explains Polpharma’s new ‘hybrid’ business model

Interview with Serge Tarabay, Senior Business Development Manager at C2 Pharma.

Jon Brice, Asymchem, explains the sustainability impact of Flow Chemistry and Biocatalysis.

Rathish Ravindrakumar explains the services the CDMO offers and the importance of sustainability to the pharma supply chain.

Olon Ricerca Bioscience is a US-based Contract Research Organisation (CRO) offering speciality chemical manufacturing capabilities.
We spoke to Alessandro Agosti, Senior Director of Scientific Operations about how they partner with customers.

In the latest episode of the PharmaSource CDMO Sessions, we speak Stephan Fritchi, Executive Vice President Business Units for CARBOGEN AMCIS.

The CDMO Sessions are a series of interviews with leaders at Contract Development and Manufacturing Organisations about what makes their business unique and to share advice for how to create better strategic partnerships. We spoke to the two Vice Presidents